Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population PK/PD Study of Liposomal Bupivacaine for Thoracic Paravertebral Analgesia After Thoracic Surgery
ChiCTR2500099289Phase 4Recruiting
- Sponsor
- Beijing Chest Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bupivacaine in acute postoperative pain, sponsored by Beijing Chest Hospital. Primary endpoint: Pharmacokinetic parameters of bupivacaine liposome population. Started Mar 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2500099289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099289.